Mechanical properties, drug eluting characteristics and in vivo performance of a genipin-crosslinked chitosan polymeric stent

Biomaterials

Volumn 30, Issue 29, 2009, Pages 5560-5571

  Chen, Mei Chin ^a   Liu, Chin Tang ^a   Tsai, Hung Wen ^b   Lai, Wei Yun ^a   Chang, Yen ^b   Sung, Hsing Wen ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Biocompatibility; Biodegradation; Crosslinking; Endothelialization; Sirolimus

Indexed keywords

ABDOMINAL AORTA; ANTI-PROLIFERATIVE; COMPRESSION LOADS; CROSS LINKED CHITOSAN; CROSS-LINKING STRUCTURES; DRUG DELIVERY VEHICLES; ENDOTHELIALIZATION; EPOXY COMPOUND; GENIPIN; IN-VIVO; LOCAL DRUG DELIVERY; MATRIX; MECHANICAL STRENGTH; METALLIC STENTS; SIROLIMUS; SMOOTH MUSCLE CELL PROLIFERATION; SUSTAINED-RELEASE; VESSEL WALLS;

BIOCHEMISTRY; BIOCOMPATIBILITY; BIODEGRADATION; BIOMECHANICS; CELL MEMBRANES; CELL PROLIFERATION; CHITIN; CHITOSAN; CROSSLINKING; DEGRADATION; DRUG DELIVERY; ENDOTHELIAL CELLS; ETHERS; MICROBIOLOGY; MUSCLE; POLYMERS; POLYSACCHARIDES;

MECHANICAL PROPERTIES;

ACETYLSALICYLIC ACID; CHITOSAN; CLOPIDOGREL; EPOXIDE; GENIPIN; HEPARIN; RAPAMYCIN;

ABDOMINAL AORTA; ANIMAL CELL; ANIMAL EXPERIMENT; ARTERY OCCLUSION; ARTICLE; BARE METAL STENT; BIOCOMPATIBILITY; BIODEGRADABILITY; COMPRESSIVE STRENGTH; CONTROLLED STUDY; CROSS LINKING; CRUSHING STRENGTH; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; MATERIAL COATING; MECHANICAL TORSION; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; SUSTAINED RELEASE PREPARATION; THORACIC AORTA; VASCULAR PATENCY; VASCULAR SMOOTH MUSCLE;

ANIMALS; CHITOSAN; COMPRESSIVE STRENGTH; CROSS-LINKING REAGENTS; DRUG-ELUTING STENTS; ELASTIC MODULUS; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; IMMUNOSUPPRESSIVE AGENTS; IRIDOID GLYCOSIDES; IRIDOIDS; POLYMERS; RABBITS; SIROLIMUS;

ORYCTOLAGUS CUNICULUS;

EID: 68549112718     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.06.039     Document Type: Article

References (32)

1. Kukreja N., Onuma Y., Daemen J., and Serruys P.W. The future of drug-eluting stents. Pharmacol Res 57 (2008) 171-180
2. Simmons A., Padsalgikar A.D., Ferris L.M., and Poole-Warren L.A. Biostability and biological performance of a PDMS-based polyurethane for controlled drug release. Biomaterials 29 (2008) 2987-2995
3. Van der Giessen W.J., Lincoff A.M., Schwartz R.S., van Beusekom H.M., Serruys P.W., Holmes Jr. D.R., et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 94 (1996) 1690-1697
4. Chen M.C., Chang Y., Liu C.T., Lai W.Y., Peng S.F., Hung Y.W., et al. The characteristics and in vivo suppression of neointimal formation with sirolimus-eluting polymeric stents. Biomaterials 30 (2009) 79-88
5. Kolhe P., and Kannan R.M. Improvement in ductility of chitosan through blending and copolymerization with PEG: FTIR investigation of molecular interactions. Biomacromolecules 4 (2003) 173-180
6. Chen M.C., Tsai H.W., Chang Y., Lai W.Y., Mi F.L., Liu C.T., et al. Rapidly self-expandable polymeric stents with a shape-memory property. Biomacromolecules 8 (2007) 2774-2780
7. Kuo C.K., and Ma P.X. Ionically crosslinked alginate hydrogels as scaffolds for tissue engineering: part 1. Structure, gelation rate and mechanical properties. Biomaterials 22 (2001) 511-521
8. Ko C.S., Wu C.H., Huang H.H., and Chu I.M. Genipin cross-linking of type II collagen-chondroitin sulfate-hyaluronan scaffold for articular cartilage therapy. J Med Biol Eng 27 (2007) 7-14
9. Cauich-Rodriguez J.V., Deb S., and Smith R. Effect of cross-linking agents on the dynamic mechanical properties of hydrogel blends of poly(acrylic acid)-poly(vinyl alcohol-vinyl acetate. Biomaterials 17 (1996) 2259-2264
10. Fujikawa S., Yokota T., Koga K., and Kumada J. The continuous hydrolysis of geniposide to genipin using immobilized β-glucosidase on calcium alginate gel. Biotechnol Lett 9 (1987) 697-702
11. Sung H.W., Chang Y., Liang I.L., Chang W.H., and Chen Y.C. Fixation of biological tissues with a naturally occurring crosslinking agent: fixation rate and effects of pH, temperature, and initial fixative concentration. J Biomed Mater Res 52 (2000) 77-87
12. Chang Y., Tsai C.C., Liang H.C., and Sung H.W. Reconstruction of the right ventricular outflow tract with a bovine jugular vein graft fixed with a naturally occurring crosslinking agent (genipin) in a canine model. J Thorac Cardiovasc Surg 122 (2001) 1209-1218
13. Stryer L. Biochemistry. 3rd ed. (1998), Freeman Press, New York p. 50-55
14. Kretsinger J.K., Haines L.A., Ozbas B., Pochan D.J., and Schneider J.P. Cytocompatibility of self-assembled beta-hairpin peptide hydrogel surfaces. Biomaterials 26 (2005) 5177-5186
15. Porter J.R., Henson A., and Popat K.C. Biodegradable poly(epsilon-caprolactone) nanowires for bone tissue engineering applications. Biomaterials 30 (2009) 780-788
16. Smith P.K., Mallia A.K., and Herrmanson G.T. Colorimetric method for the assay of heparin content in immobilized heparin preparations. Anal Biochem 109 (1980) 466-473
17. Blindt R., Vogt F., Astafieva I., Fach C., Hristov M., Krott N., et al. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells. J Am Coll Cardiol 47 (2006) 1786-1795
18. Vogt F., Stein A., Rettemeier G., Krott N., Hoffmann R., vom Dahl J., et al. Long-term assessment of a novel biodegradable paclitaxel-eluting coronary polylactide stent. Eur Heart J 25 (2004) 1330-1340
19. Chen M.C., Tsai H.W., Liu C.T., Peng S.F., Lai W.Y., Chen S.J., et al. A nanoscale drug-entrapment strategy for hydrogel-based systems for the delivery of poorly soluble drugs. Biomaterials 30 (2009) 2102-2111
20. Marx S.O., Jayaraman T., Go L.O., and Marks A.R. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res 76 (1995) 412-417
21. Rosner D., McCarthy N., and Bennett M. Rapamycin inhibits human in stent restenosis vascular smooth muscle cells independently of pRB phosphorylation and p53. Cardiovasc Res 66 (2005) 601-610
22. Hu Y., Jiang X., Ding Y., Ge H., Yuan Y., and Yang C. Synthesis and characterization of chitosan-poly(acrylic acid) nanoparticles. Biomaterials 23 (2002) 3193-3201
23. Ostroha J., Pong M., Lowman A., and Dan N. Controlling the collapse/swelling transition in charged hydrogels. Biomaterials 25 (2004) 4345-4353
24. Petrache H.I., Zemb T., Belloni L., and Parsegian V.A. Salt screening and specific ion adsorption determine neutral-lipid membrane interactions. Proc Natl Acad Sci U S A 103 (2006) 7982-7987
25. Hirano S., Tsuchida H., and Nagao N. N-acetylation in chitosan and the rate of its enzymic hydrolysis. Biomaterials 10 (1989) 574-576
26. Sung H.W., Hsu C.S., Lee Y.S., and Lin D.S. Crosslinking characteristics of an epoxy-fixed porcine tendon: effects of pH, temperature, and fixative concentration. J Biomed Mater Res 31 (1996) 511-518
27. Sung H.W., Liang I.L., Chen C.N., Huang R.N., and Liang H.F. Stability of a biological tissue fixed with a naturally occurring crosslinking agent (genipin). J Biomed Mater Res 55 (2001) 538-546
28. Rabkin D.J., Lang E.V., and Brophy D.P. Nitinol properties affecting uses in interventional radiology. J Vasc Interv Radiol 11 (2000) 343-350
29. Koo H.J., Song Y.S., Kim H.J., Lee Y.H., Hong S.M., Kim S.J., et al. Antiinflammatory effects of genipin, an active principle of gardenia. Eur J Pharmacol 495 (2004) 201-208
30. Schneider P.A., Hanson S.R., Price T.M., and Harker L.A. Confluent durable endothelialization of endarterectomized baboon aorta by early attachment of cultured endothelial cells. J Vasc Surg 11 (1990) 365-372
31. Yin M., Yuan Y., Liu C., and Wang J. Development of mussel adhesive polypeptide mimics coating for in-situ inducing re-endothelialization of intravascular stent devices. Biomaterials 30 (2009) 2764-2773
32. Sindermann J.R., Verin V., Hopewell J.W., Rodemann H.P., and Hendry J.H. Biological aspects of radiation and drug-eluting stents for the prevention of restenosis. Cardiovasc Res 63 (2004) 22-30